Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:659-665

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matrougui, K.
Right arrow Articles by Henrion, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matrougui, K.
Right arrow Articles by Henrion, D.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 1999;34:659-665.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Activation of AT2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance Arteries

Khalid Matrougui; Laurent Loufrani; Christophe Heymes; Bernard I. Lévy; Daniel Henrion

From the Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 141 (K.M., L.L., B.I.L., D.H.) and Unit 127 (C.H.), IFR 6, Université Paris VII, France.

Correspondence to D. Henrion, PhD, INSERM Unit 141, Hopital Lariboisiere, 41 Blvd de la Chapelle, 75475 Paris, cedex 10, France. E-mail daniel.henrion{at}inserm.lrb.ap-hop-paris.fr

Abstract—Pressure-induced tone (myogenic, MT) and flow (shear stress)–induced dilation (FD) are potent modulators of resistance artery tone. We tested the hypothesis that locally produced angiotensin II interacts with MT and FD. Rat mesenteric resistance arteries were perfused in situ. Arterial diameter was measured by intravital microscopy after a bifurcation on 2 distal arterial branches equivalent in size (150 µm, n=7 per group). One was ligated distally and thus submitted to pressure only (MT, no FD). The second branch was submitted to flow and pressure (MT and FD). The difference in diameter between the 2 vessels was considered to be FD. Flow-diameter-pressure relationship was established in the absence and then in the presence of 1 of the following agents. In the nonligated segment (MT+FD), angiotensin II type 1 (AT1) receptor blockade (losartan) had no significant effect, whereas angiotensin II type 2 (AT2) receptor blockade (PD123319) or saralasin (AT1+AT2 blocker) decreased the diameter significantly, by 9±1 and 10±0.8 µm, respectively. Angiotensin II in the presence of losartan increased the diameter by 18±0.6 µm (inhibited by PD123319). PD123319 or saralasin had no effect after NO synthesis blockade or after endothelial disruption. In the arterial segment ligated distally (MT only), AT1 or AT2 receptor blockade had no significant effect. AT2-dependent dilation represented 20% to 39% of FD (shear stress from 22 to 37 dyn/cm2), and AT2-receptor mRNA was found in mesenteric resistance arteries. Thus, resistance arterial tone was modulated in situ by locally produced angiotensin II, which might participate in flow-induced dilation through endothelial AT2 receptor activation of NO release.


Key Words: blood vessels • myogenic • arteries • stress, mechanical • angiotensin II • bradykinin




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Su, P. A. Lucchesi, R. A. Gonzalez-Villalobos, D. I. Palen, B. M. Rezk, Y. Suzuki, H. A. Boulares, and K. Matrougui
Role of Advanced Glycation End Products With Oxidative Stress in Resistance Artery Dysfunction in Type 2 Diabetic Mice
Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1432 - 1438.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Pinaud, A. Bocquet, O. Dumont, K. Retailleau, C. Baufreton, R. Andriantsitohaina, L. Loufrani, and D. Henrion
Paradoxical Role of Angiotensin II Type 2 Receptors in Resistance Arteries of Old Rats
Hypertension, July 1, 2007; 50(1): 96 - 102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. A. Arenas, Y. Xu, and S. T. Davidge
Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-{alpha} antagonism
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1259 - H1263.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Brassard, F. Amiri, and E. L. Schiffrin
Combined Angiotensin II Type 1 and Type 2 Receptor Blockade on Vascular Remodeling and Matrix Metalloproteinases in Resistance Arteries
Hypertension, September 1, 2005; 46(3): 598 - 606.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Guimaraes and H. Pinheiro
Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally
Cardiovasc Res, August 1, 2005; 67(2): 208 - 215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Duke, R. G. Evans, and R. E Widdop
AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2289 - H2297.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Gonzalez, L. Lobos, F. Castillo, L. Galleguillos, N. C. Lopez, and L. Michea
High-Salt Diet Inhibits Expression of Angiotensin Type 2 Receptor in Resistance Arteries
Hypertension, May 1, 2005; 45(5): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. You, L. Loufrani, C. Baron, B. I. Levy, R. E. Widdop, and D. Henrion
High Blood Pressure Reduction Reverses Angiotensin II Type 2 Receptor-Mediated Vasoconstriction Into Vasodilation in Spontaneously Hypertensive Rats
Circulation, March 1, 2005; 111(8): 1006 - 1011.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Lucchesi, A. Sabri, S. Belmadani, and K. Matrougui
Involvement of Metalloproteinases 2/9 in Epidermal Growth Factor Receptor Transactivation in Pressure-Induced Myogenic Tone in Mouse Mesenteric Resistance Arteries
Circulation, December 7, 2004; 110(23): 3587 - 3593.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Bergaya, R. H.P. Hilgers, P. Meneton, Y. Dong, M. Bloch-Faure, T. Inagami, F. Alhenc-Gelas, B. I. Levy, and C. M. Boulanger
Flow-Dependent Dilation Mediated by Endogenous Kinins Requires Angiotensin AT2 Receptors
Circ. Res., June 25, 2004; 94(12): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Liu, S. Mather, Y. Huang, C. J. Garland, and X. Yao
Extracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1688 - H1695.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Hornig, C. Kohler, D. Schlink, H. Tatge, and H. Drexler
AT1-Receptor Antagonism Improves Endothelial Function in Coronary Artery Disease by a Bradykinin/B2-Receptor-Dependent Mechanism
Hypertension, May 1, 2003; 41(5): 1092 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Armando, M. Jezova, A. V. Juorio, J. A. Terron, A. Falcon-Neri, C. Semino-Mora, H. Imboden, and J. M. Saavedra
Estrogen upregulates renal angiotensin II AT2 receptors
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F934 - F943.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Loufrani, Z. Li, B. I. Levy, D. Paulin, and D. Henrion
Excessive Microvascular Adaptation to Changes in Blood Flow in Mice Lacking Gene Encoding for Desmin
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1579 - 1584.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. E. Widdop, K. Matrougui, B. I. Levy, and D. Henrion
AT2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT1 Receptor Blockade
Hypertension, October 1, 2002; 40(4): 516 - 520.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Besnard, J. Bakouche, Y. Lemaigre-Dubreuil, J. Mariani, A. Tedgui, and D. Henrion
Smooth Muscle Dysfunction in Resistance Arteries of the Staggerer Mouse, a Mutant of the Nuclear Receptor ROR{alpha}
Circ. Res., April 19, 2002; 90(7): 820 - 825.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Shimizu-Hirota, H. Sasamura, M. Mifune, H. Nakaya, M. Kuroda, M. Hayashi, and T. Saruta
Regulation of Vascular Proteoglycan Synthesis by Angiotensin II Type 1 and Type 2 Receptors
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2609 - 2615.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy
Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats
Hypertension, December 1, 2001; 38(6): 1272 - 1277.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Henrion, N. Kubis, and B. I. Levy
Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation
Hypertension, November 1, 2001; 38(5): 1150 - 1157.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Ichihara, T. Senbonmatsu, E. Price Jr, T. Ichiki, F. A. Gaffney, and T. Inagami
Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II-Induced Hypertension
Circulation, July 17, 2001; 104(3): 346 - 351.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey
Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats
Hypertension, May 1, 2001; 37(5): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Bergaya, P. Meneton, M. Bloch-Faure, E. Mathieu, F. Alhenc-Gelas, B. I. Levy, and C. M. Boulanger
Decreased Flow-Dependent Dilation in Carotid Arteries of Tissue Kallikrein-Knockout Mice
Circ. Res., March 30, 2001; 88(6): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Loufrani, K. Matrougui, D. Gorny, M. Duriez, I. Blanc, B. I. Levy, and D. Henrion
Flow (Shear Stress)-Induced Endothelium-Dependent Dilation Is Altered in Mice Lacking the Gene Encoding for Dystrophin
Circulation, February 13, 2001; 103(6): 864 - 870.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Mifune, H. Sasamura, R. Shimizu-Hirota, H. Miyazaki, and T. Saruta
Angiotensin II Type 2 Receptors Stimulate Collagen Synthesis in Cultured Vascular Smooth Muscle Cells
Hypertension, November 1, 2000; 36(5): 845 - 850.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Besnard, J. Bakouche, Y. Lemaigre-Dubreuil, J. Mariani, A. Tedgui, and D. Henrion
Smooth Muscle Dysfunction in Resistance Arteries of the Staggerer Mouse, a Mutant of the Nuclear Receptor ROR{alpha}
Circ. Res., April 19, 2002; 90(7): 820 - 825.
[Abstract] [Full Text] [PDF]